🇺🇸 FDA
Pipeline program

CAR-T

2024-Lunli-020

Phase 1 mab active

Quick answer

CAR-T for Multiple Myeloma is a Phase 1 program (mab) at The Third Affiliated Hospital of Southern Medical University with 1 ClinicalTrials.gov record(s).

Program details

Company
The Third Affiliated Hospital of Southern Medical University
Indication
Multiple Myeloma
Phase
Phase 1
Modality
mab
Status
active

Clinical trials